Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use.
作者信息
Llerena A, Kiivet R A
机构信息
Department of Pharmacology and Psychiatry, University of Extremadura, Badajoz, Spain.
出版信息
Br J Clin Pharmacol. 1994 Jun;37(6):531-2. doi: 10.1111/j.1365-2125.1994.tb04299.x.
Abstract
摘要
相似文献
1
Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use.抗精神病药与抗抑郁药的固定组合：潜在风险及使用评估
Br J Clin Pharmacol. 1994 Jun;37(6):531-2. doi: 10.1111/j.1365-2125.1994.tb04299.x.
2
Drug metabolism and psychiatry: introduction.药物代谢与精神病学：引言
Cell Mol Neurobiol. 1999 Jun;19(3):301-8. doi: 10.1023/a:1006941614219.
3
Interethnic differences in drug oxidation. Implications for the utilization of antidepressants and neuroleptics.药物氧化的种族间差异。对抗抑郁药和抗精神病药使用的影响。
Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:88A-89A. doi: 10.1097/00002826-199201001-00047.
4
Appropriate use of neuroleptics and antidepressants in the geriatric patient.老年患者中抗精神病药物和抗抑郁药物的合理使用。
South Med J. 1991 May;84(5 Suppl 1):S53-6.
5
Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.药物遗传学方法作为抗抑郁药和抗精神病药治疗监测的补充
Ther Drug Monit. 2000 Feb;22(1):114-7. doi: 10.1097/00007691-200002000-00024.
6
Common drug interactions following traumatic brain injury.
J Head Trauma Rehabil. 2013 Mar-Apr;28(2):151-4. doi: 10.1097/HTR.0b013e31823a5086.
7
[Characteristics of the interaction of neuroleptics and antidepressants with plasma proteins (review of the literature)].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(9):116-24.
8
[Antidepressant pharmacokinetics during pregnancy].[孕期抗抑郁药的药代动力学]
Eksp Klin Farmakol. 2013;76(1):14-20.
9
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.抗抑郁药和抗精神病药的药物遗传学：等位基因变异对药物反应表型的影响。
Mol Psychiatry. 2004 May;9(5):442-73. doi: 10.1038/sj.mp.4001494.
10
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents.使用抗精神病药和抗抑郁药治疗的患者中异喹胍和甲妥英的羟化表型及CYP2D6基因型
Clin Pharmacol Ther. 1993 Dec;54(6):606-11. doi: 10.1038/clpt.1993.197.
本文引用的文献
1
Debrisoquin oxidation polymorphism in a Spanish population.
Clin Pharmacol Ther. 1988 Jul;44(1):74-7. doi: 10.1038/clpt.1988.115.
2
Clinical significance of the sparteine/debrisoquine oxidation polymorphism.司巴丁/异喹胍氧化多态性的临床意义
Eur J Clin Pharmacol. 1989;36(6):537-47. doi: 10.1007/BF00637732.
Zotero 插件